Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RotaTeq + IPV co-administration vs staggered administration in healthy Chinese infants
CTR20201103Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent, trivalent inactivated polio vaccine in rotaviral diarrhea, poliomyelitis, sponsored by Merck & Co.. Started Jun 2020; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalenttrivalent inactivated polio vaccine
03
Conditions
rotaviral diarrheapoliomyelitis
Beyond the preview
Go deeper on CTR20201103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201103.